Managers / Q1 2022 · view latest →
Avenir Management Company, LLC
CIK 0001866419 · 817 BROADWAY, 12TH FLOOR, NEW YORK, NY, 10003 · 516-318-6545
Summary
Avenir Management Company, LLC reported $109M in U.S.-listed holdings across 4 positions for Q1 2022.
The portfolio is heavily concentrated: LTCH alone accounts for 83.7% of reported value.
Compared with Q4 2021, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 92.3% · $101M
- Other · 7.7% · $8M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CVNACARVANA CO | NEW | +24.2K | 24.2K | +$3M | $3M |
| LTCHLATCH INC | HELD | +0 | 21.44M | −$71M | $92M |
| FINCH THERAPEUTICS GROUP INC | HELD | +0 | 1.66M | −$8M | $8M |
| UBERUBER TECHNOLOGIES INC | HELD | +0 | 183.3K | −$1M | $7M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | LTCHLATCH INChistory → | COM | 83.72% | $92M | 21.44M |
| 2 | FINCH THERAPEUTICS GROUP INC | COM | 7.65% | $8M | 1.66M |
| 3 | UBERUBER TECHNOLOGIES INChistory → | COM | 5.98% | $7M | 183.3K |
| 4 | CVNACARVANA COhistory → | CL A | 2.64% | $3M | 24.2K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $44M | 4 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $37M | 4 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $20M | 4 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $43M | 6 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $59M | 6 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $58M | 6 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $109M | 4 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $187M | 3 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.